Patents Examined by Narayan Bhat
  • Patent number: 9689033
    Abstract: Methods and compositions for characterizing a target polynucleotide, including, characterizing the sequence of the target polynucleotide, using the fractional translocation steps of the target polynucleotide's translocation through a pore.
    Type: Grant
    Filed: November 26, 2014
    Date of Patent: June 27, 2017
    Assignee: Illumina, Inc.
    Inventors: Eric Stava, Jens H. Gundlach, Jeffrey G. Mandell, Kevin L. Gunderson, Ian M. Derrington, Hosein Mohimani
  • Patent number: 9689037
    Abstract: This document provides methods and materials for detecting genetic and/or epigenetic elements. For example, methods and materials for detecting the presence or absence of target nucleic acid containing a genetic or epigenetic element, methods and materials for detecting the amount of target nucleic acid containing a genetic or epigenetic element within a sample, kits for detecting the presence or absence of target nucleic acid containing a genetic or epigenetic element, kits for detecting the amount of target nucleic acid containing a genetic or epigenetic element present within a sample, and methods for making such kits are provided.
    Type: Grant
    Filed: August 31, 2015
    Date of Patent: June 27, 2017
    Assignee: Cascade Biosystems, Inc.
    Inventors: Kenneth D. Smith, Nina Yazvenko, Mariya Smit
  • Patent number: 9683792
    Abstract: The present invention generally pertains to a system which utilizes floating thermal contact to enable PCR, in a thermal management device. Comprised of multiple thermal zones attached to a framework, each zone an individually actuated, isolated sub-assembly. The actuation of each zone ensures physical contact with an uneven, yet flat microfluidic chip to achieve effective, conductive heat transfer. The isolation of each zone serves to insulate the thermal zones from each other and minimize undesired heat transfer between adjacent zones, so that each zone is at a proper, uniform temperature.
    Type: Grant
    Filed: June 30, 2015
    Date of Patent: June 20, 2017
    Assignee: Bio-Rad Laboratories, Inc.
    Inventors: Christopher Possinger, Sepehr Kiani
  • Patent number: 9683960
    Abstract: The present invention provides a system including: a peptide nucleic acid (PNA) molecule; a DNA molecule, an RNA molecule, or a combination thereof; and an Isotachophoresis (ITP) system. Furthermore, the invention provides a method for sequence-specifically separating and/or identifying a nucleic acid molecule of interest by utilizing the system of the invention to separate and possibly label and/or detect a nucleic acid molecule of interest.
    Type: Grant
    Filed: August 18, 2014
    Date of Patent: June 20, 2017
    Assignee: Technion Research and Development Foundation Limited
    Inventors: Moran Bercovici, Nadya Ostromohov, Ortal Schwartz
  • Patent number: 9677066
    Abstract: Compositions and methods for separating double-stranded nucleic acids out of a mixture comprising single-stranded nucleic acids and/or dNTPs and/or enzymes. The method uses spatially inhomogeneously functionalized nanoporous materials. For example, the compositions and methods of the present invention can be used to purify DNA amplification reaction products.
    Type: Grant
    Filed: May 29, 2015
    Date of Patent: June 13, 2017
    Assignee: The University of Rochester
    Inventors: Lewis Rothberg, Barbara Stwertka
  • Patent number: 9670526
    Abstract: Methods and related products are disclosed that improve the probability of interaction between a target molecule and a nanopore by capturing the target molecule on a surface comprising the nanopore. The captured target molecule, the nanopore, or both, are able to move relative to each other along the surface. When the leader of the target molecule is in proximity with the nanopore, interaction of the target portion of the target molecule with the nanopore occurs, thereby permitting sensing of the target portion. Confining the target molecule and nanopore in this manner leads to significantly enhanced interaction with the nanopore.
    Type: Grant
    Filed: November 8, 2013
    Date of Patent: June 6, 2017
    Assignee: Stratos Genomics, Inc.
    Inventors: Mark Stamatios Kokoris, Robert N. McRuer
  • Patent number: 9671403
    Abstract: The present invention encompasses a method for detecting a target comprising a repeating epitope.
    Type: Grant
    Filed: March 30, 2015
    Date of Patent: June 6, 2017
    Assignees: MEDIOMICS, LLC, SAINT LOUIS UNIVERSITY
    Inventors: Tomasz Heyduk, Ling Tian
  • Patent number: 9638612
    Abstract: A method of individually releasing from an entity one or more members of a sub-group of biological units included in a heterogeneous group of biological units is provided. The method includes binding the group of biological units including the sub-group of biological units to the entity via a linker. Following binding, the location of the one or more members on the entity is determined. Once the location is determined, a localized physical pulse is applied to the one or more members. The localized physical pulse individually releases the one or more members from the entity by dissociating the linker.
    Type: Grant
    Filed: April 25, 2014
    Date of Patent: May 2, 2017
    Assignee: Roche Molecular Systems, Inc.
    Inventors: Judith Brand-Meier, Claudio Cherubini, Andreas Drechsler, Nicole Gwerder, Martin Kopp, Edwin Oosterbroek, Emad Sarofim
  • Patent number: 9637781
    Abstract: The present invention provides a PCR-free, multiplexed ligation assay for miRNA expression analysis that produces highly quantitative, 10-100 plex miRNA profiling in a single reaction. The inventive methods use a 2-step ligation assay to generate an array of miRNA specific ligation products that can be decoded and quantified by a size discrimination method such as gel electrophoresis or single molecule separation. One embodiment is a low-cost assay that can be performed using standard tools available in nearly all molecular biology laboratories. This assay requires nothing more than a gel apparatus and reader for detection. Other embodiments include use of magnetic beads and other size exclusion apparatus which give increasingly higher sensitivity, lower sample consumption, and reduced processing steps.
    Type: Grant
    Filed: February 13, 2013
    Date of Patent: May 2, 2017
    Assignee: The Johns Hopkins University
    Inventors: Tza-Huei Wang, Kelvin J. Liu, Yunke Song
  • Patent number: 9637777
    Abstract: Disclosed are methods of multiplexed analysis of oligonucleotides in a sample, including a method of preventing a significant reduction in duplexes detectable in a hybridization assay involving (i) selecting probe lengths for sets of oligonucleotide probes, wherein probes include different subsequences such that at least one subsequence is complementary to a subsequence in a cognate target; wherein probes for longer cognate targets are longer in length than probes for shorter cognate targets, (ii) selecting, for each set of probes, a density of oligonucleotides probes attached per unit area on a solid phase carrier which is below a limit at which the significant reduction in detectable duplexes is predicated to take place, (iii) producing the probes and affixing them to different solid phase carriers at the selected density, and (iv) annealing targets to the probes, wherein signal intensities of probes and targets of different lengths are about the same.
    Type: Grant
    Filed: April 21, 2014
    Date of Patent: May 2, 2017
    Assignee: BioArray Solutions, Ltd.
    Inventors: Michael Seul, Sukanta Banerjee, Jiacheng Yang, Tatiana Vener
  • Patent number: 9632081
    Abstract: A detection method for a specific biological substance uses, as a color former, fluorescent substance-encapsulated nanoparticles which have biological substance-recognizing molecules. The biological substance-recognizing molecules specifically recognize a specific biological substance. The biological substance-recognizing molecules are bonded to the surface of the nanoparticles. Nanoparticles encapsulating no fluorescent substance are used as a blocking agent for preventing the fluorescent substance-encapsulated nanoparticles from being non-specifically adsorbed on a biological substance other than the specific biological substance.
    Type: Grant
    Filed: March 25, 2013
    Date of Patent: April 25, 2017
    Assignee: KONICA MINOLTA, INC.
    Inventors: Hideki Hoshino, Hideki Gouda, Kensaku Takanashi, Yasushi Nakano, Kohsuke Gonda, Noriaki Ohuchi, Mika Watanabe
  • Patent number: 9632033
    Abstract: A technique relates to determining a presence of a known nucleic acid sequence of a known molecule in a sample. A sample surface is coated with a select segment of the known molecule. Beads are coated with a first molecule. A targeted nucleic acid sequence is attached to a second molecule that binds to the first molecule, such that the targeted nucleic acid sequence is attached to the beads via first and second molecules. The sample is placed on the sample surface. The sample includes the liquid medium, beads, and targeted nucleic acid sequence being tested. Brownian motion of beads is monitored to determine whether the Brownian motion of the beads is restricted or not restricted. When the Brownian motion of beads is restricted, the presence of the known nucleic acid sequence is in the sample, thus indicating that the targeted nucleic acid sequence is the known nucleic acid sequence.
    Type: Grant
    Filed: June 22, 2015
    Date of Patent: April 25, 2017
    Assignee: INTERNATIONAL BUSINESS MACHINES CORPORATION
    Inventors: Venkat K. Balagurusamy, Stephen J. Heisig, Gong Su
  • Patent number: 9624252
    Abstract: The invention provides methods and kits for nucleic acid purification and fragment selection and recovery. By adjusting salt concentrations and/or pH of the binding buffers, only nucleic acid fragments with desired size ranges are able to reversibly and non-specifically bind to a solid surface in certain salt concentrations and/or pH conditions, and can be subsequently eluted and/or recovered from the solid surface in water and/or a low salt eluting buffer.
    Type: Grant
    Filed: December 1, 2014
    Date of Patent: April 18, 2017
    Assignee: Omega Bio-tek, Inc.
    Inventor: Qi Guo
  • Patent number: 9624536
    Abstract: A microfluidic chip for use in multiplexed analysis of samples is described. The microfluidic chip comprises a plurality of sensing chambers and further comprises at least a first fluid supply channel for providing a first fluid and a plurality of microfluidic channels. These are in fluid communication with at least one sensing chamber and with the first fluid supply channel for delivery of said first fluid to the at least one sensing chamber. The microfluidic channels are branching off from the supply channel in the neighborhood of the sensing chamber that can be provided with the first fluid through the microfluidic channel. The different channels thus form a tree-like delivery distribution system for supplying the first fluid to said plurality of sensing chambers.
    Type: Grant
    Filed: May 2, 2013
    Date of Patent: April 18, 2017
    Assignee: IMEC
    Inventor: Peter Peumans
  • Patent number: 9624530
    Abstract: The present invention relates to methods and kits for preserving genomic DNA sequence complexity within chemically and/or enzymatically converted DNA by an enzyme or series of enzymes that adds a methyl group to a cytosine outside of CpG dinucleotide sequences of genomic DNA. Further, the present invention relates to methylation analysis of the genomic DNA.
    Type: Grant
    Filed: August 2, 2010
    Date of Patent: April 18, 2017
    Assignee: EPIGENOMICS AG
    Inventor: Joern Lewin
  • Patent number: 9618505
    Abstract: The invention generally provides two-component molecular biosensors. In particular, the invention provides molecular biosensors having peptide epitope binding agents that bind a target antibody. The molecular biosensors are useful in several methods including in the identification and quantification of target molecules.
    Type: Grant
    Filed: February 16, 2015
    Date of Patent: April 11, 2017
    Assignee: MEDIOMICS, LLC
    Inventors: Tomasz Heyduk, Ling Tian, Rongsheng E. Wang, Yie-Hwa Chang
  • Patent number: 9599609
    Abstract: The present invention discloses analyte detection devices for detecting one or more analytes present in test samples, especially biological samples. In particular, the devices of the invention are lateral flow assay devices comprising immobilized metal nanoparticle conjugates as the detection means. Methods of using the devices and kits comprising the devices are also described.
    Type: Grant
    Filed: August 26, 2014
    Date of Patent: March 21, 2017
    Assignee: ABAXIS, INC.
    Inventors: Rajesh K. Mehra, Kenneth P. Aron
  • Patent number: 9574232
    Abstract: Devices and methods for controlling reversible chemical reactions at solid-liquid interfaces are disclosed. In particular, the invention relates to a method of increasing reaction rates by concentrating a target molecule in a liquid phase in the region of a reactant or ligand immobilized on a solid followed by removal of the liquid phase and replacement with an immiscible phase, such as an immiscible gas or liquid to impede the reverse reaction. Devices for performing this method to increase the rates and degree of completion of kinetically limited ligand binding or nucleic acid hybridization reactions in affinity chromatography and microarray applications are also disclosed.
    Type: Grant
    Filed: February 24, 2015
    Date of Patent: February 21, 2017
    Assignee: The Board of Trustees of the Leland Stanford Junior University
    Inventors: Crystal Han, Juan G. Santiago, Viktor Shkolnikov
  • Patent number: 9567633
    Abstract: A method for detecting hydroxymethylation modification in nucleic acid comprises: glycosylating the nucleic acid, digesting with MspI, ligating the digested fragments to a biotin-labeled linker at both ends thereof, digesting with NlaIII; capturing the digested fragments using streptavidin magnetic beads to produce fragments having the biotin-labeled linker at one end and a CATG 4-base sticky end at the other end, wherein these fragments reveal modification information of their adjacent CCGG sites; ligating the CATG sticky end to a linker containing a recognition site of MmeI or Ecop15I, digesting with corresponding restriction endonuclease to produce short sequence fragments that can reveal modification information of their adjacent CCGG sites; and performing a tag number comparison to obtain information about methylation and hydroxymethylation modification relative levels. A use of the method is also provided.
    Type: Grant
    Filed: November 21, 2012
    Date of Patent: February 14, 2017
    Assignee: BGI TECH SOLUTIONS CO., LTD.
    Inventors: Fei Gao, Junwen Wang, Xiuqing Zhang, Huanming Yang
  • Patent number: 9566558
    Abstract: The present invention concerns a microfluidic device (1) for performing physical, chemical or biological treatment to at least one packet without contamination.
    Type: Grant
    Filed: September 9, 2005
    Date of Patent: February 14, 2017
    Assignees: INSTITUT CURIE, CENTRE NATIONAL DE RECHERCHE SCIENTIFIQUE
    Inventors: Jean-Louis Viovy, Max Chabert, Kevin Dorfman